Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation()

Chemotherapy-induced peripheral neuropathy (CIPN) is a severe and dose-limiting side effect of cancer treatment that affects millions of cancer survivors throughout the world and current treatment options are extremely limited by their side effects. Cannabinoids are highly effective in suppressing p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuropharmacology
Main Authors: Mulpuri, Yatendra, Marty, Vincent N., Munier, Joseph J., Mackie, Ken, Schmidt, Brian L., Seltzman, Herbert H., Spigelman, Igor
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6883926/
https://ncbi.nlm.nih.gov/pubmed/29981335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2018.07.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados